CHPF2 anticorps (N-Term)
Aperçu rapide pour CHPF2 anticorps (N-Term) (ABIN631398)
Antigène
Voir toutes CHPF2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- CSGLCA-T antibody was raised against the N terminal Of Csglca-T
-
Purification
- Affinity purified
-
Immunogène
- CSGLCA-T antibody was raised using the N terminal Of Csglca-T corresponding to a region with amino acids SLLRVSWIQGEGEDPCVEAVGERGGPQNPDSRARLDQSDEDFKPRIVPYY
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
CSGLCA-T Blocking Peptide, (ABIN5613016), is also available for use as a blocking control in assays to test for specificity of this CSGLCA-T antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CSGLCA-T antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CHPF2 (Chondroitin Polymerizing Factor 2 (CHPF2))
-
Autre désignation
- CSGLCA-T
-
Sujet
- CSGlcA-T belongs to the chondroitin N-acetylgalactosaminyltransferase family. It transfers glucuronic acid (GlcUA) from UDP-GlcUA to N-acetylgalactosamine residues on the non-reducing end of the elongating chondroitin polymer. CSGlcA-T has no N-acetylgalactosaminyltransferase activity.
-
Poids moléculaire
- 18 kDa (MW of target protein)
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-